MICAELA PERKINS: Open Payments
NPI 1598130114 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,335 in 180 payments from 20 companies in 2025. Trend: 2023 $3,497 · 2024 $3,861 · 2025 $3,335
Food & beverage: $3,335
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $660 |
| Amgen Inc. | 34 | $598 |
| Novartis Pharmaceuticals Corporation | 35 | $372 |
| UCB, Inc. | 15 | $306 |
| Janssen Biotech, Inc. | 11 | $227 |
| AstraZeneca Pharmaceuticals LP | 9 | $171 |
| Organon LLC | 6 | $141 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $120 |
| Fresenius Kabi USA, LLC | 5 | $120 |
| GENZYME CORPORATION | 4 | $107 |
Products named: RINVOQ, COSENTYX, OTEZLA, Bimzelx, TREMFYA, SKYRIZI, SAPHNELO, HADLIMA.
Industry payments across MS — which companies pay providers there.
